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Abstract
Background: There exist several computational tools which allow for the optimisation and inference of biological networks
using a Boolean formalism. Nevertheless, the results from such tools yield only limited quantitative insights into the
complexity of biological systems because of the inherited qualitative nature of Boolean networks.
Results: We introduce optPBN, a Matlab-based toolbox for the optimisation of probabilistic Boolean networks (PBN) which
operates under the framework of the BN/PBN toolbox. optPBN offers an easy generation of probabilistic Boolean networks
from rule-based Boolean model specification and it allows for flexible measurement data integration from multiple
experiments. Subsequently, optPBN generates integrated optimisation problems which can be solved by various
optimisers. In term of functionalities, optPBN allows for the construction of a probabilistic Boolean network from a given
set of potential constitutive Boolean networks by optimising the selection probabilities for these networks so that the
resulting PBN fits experimental data. Furthermore, the optPBN pipeline can also be operated on large-scale computational
platforms to solve complex optimisation problems. Apart from exemplary case studies which we correctly inferred the
original network, we also successfully applied optPBN to study a large-scale Boolean model of apoptosis where it allows
identifying the inverse correlation between UVB irradiation, NFkB and Caspase 3 activations, and apoptosis in primary
hepatocytes quantitatively. Also, the results from optPBN help elucidating the relevancy of crosstalk interactions in the
apoptotic network.
Summary: The optPBN toolbox provides a simple yet comprehensive pipeline for integrated optimisation problem
generation in the PBN formalism that can readily be solved by various optimisers on local or grid-based computational
platforms. optPBN can be further applied to various biological studies such as the inference of gene regulatory networks or
the identification of the interaction’s relevancy in signal transduction networks.
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Introduction
The Boolean network (BN) modelling framework was first
introduced by Kauffmann in 1969 for the study of gene regulatory
networks [1]. It has been widely applied to analyse the dynamics of
different biological systems such as the gene regulatory network of
the yeast cell cycle [2], T-cell signalling [3], signal transduction in
the apoptotic pathway [4] and many more. For an overview see,
e.g., [5,6]. Despite its simplicity, the framework has been shown to
be capable of modelling large-scale biological networks and
providing meaningful biological interpretations, e.g., the attractors
can be correlated to different cellular states [7]. Nevertheless, BNs
only provide a very limited quantitative insight into biological
systems due to their inherent qualitative nature of state and time.
In 2002, the probabilistic Boolean network (PBN) modelling
framework was introduced by Ilya Shmulevich and colleagues for
the modelling of gene regulatory networks [8]. PBNs combine the
rule-based modelling of Boolean networks with uncertainty
principles as described by Markov chains [8,9]. The PBN
formalism allows multiple Boolean functions to be assigned to a
certain node with corresponding selection probabilities. This
assignment forms a collection of Boolean networks (so-called
constituent networks) that are being randomly chosen in accordance
with their selection probabilities throughout the course of a
simulation of the PBN. A constituent Boolean network determin-
ing the state transition of the PBN is randomly chosen at each
epoch in an instantaneously random PBN, while the transition
determining constituent Boolean network remains constant for a
period of time until a binary random variable asks for a switch in a
context-sensitive PBN [10]. Modelling with PBNs provides a
quantitative understanding of biological systems. For example,
interactive effects (so called influences) between certain genes [8] or
average activities of certain genes given by steady-state probabil-
ities [7] can be computed and expressed in quantitative terms.
Over the past years, PBNs have been widely applied to study
various biological systems. For instance, Yu et al. inferred a gene
regulatory network of the interferon pathway in macrophages
from time-course gene expression data via the calculation of
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Coefficient of Determination (CoD) to determine the selection
probability of each predictor function [11]. Using a similar
approach, Ma et al. inferred a brain connectivity network from
functional Magnetic Resonance Imaging (fMRI) data where the
influence of each brain compartment in patients with Parkinson’s
disease could be determined [12]. In recent years, Flo¨ttmann et al.
modelled the regulatory processes taking place during the
production of induced pluripotent stem cells by combining the
interplay between gene expression, chromatin modification, and
DNA methylation [13]. An extensive analysis on the PBN model
of Flo¨ttmann et al. suggests possible interventions on gene
regulation which might be further developed into clinical
applications. For more examples, see [6,14,15,16], where, among
others, PBN models for the pathogenesis of dengue viral infection
and the transcriptional programming during C. elegans develop-
ment, are discussed.
To facilitate the building of BN and PBN models as a
representation of biological systems, several computational tools
have been developed which can be applied for the optimisation
and inference of models in a Boolean formalism. For instance,
CellNetOptimiser (CellNOpt a.k.a. CNO) by Saez-Rodriguez et al. [17]
was used for the inference of a signal transduction network from
high-throughput sandwich immunoassay data [18]. Dynamic
Deterministic Effects Propagation Networks (DDEPN) by Bender et al.
allows for the reconstruction of signalling networks based on time-
course experimental data [19]. La¨hdesma¨ki and Shmulevich
introduced BN/PBN toolbox [20], a Matlab-based toolbox which
allows for the simulation, visualisation and analysis of BN and
PBN models. BN/PBN toolbox also provides a pipeline for network
inference in both the BN and PBN formalisms based on
experimental measurements such as microarray data. The network
inference process is performed via the calculation of the CoD by
exploring the error size of a given Boolean function (or so-called
predictor) compared to data. The state transition probabilities and
the influences that determine the interactive effect for each pair of
molecules (such as genes) are subsequently calculated. The BN/
PBN toolbox was initially designed for the inference and analysis of
gene regulatory networks [20]. However, it was also applied for
the study of different biological systems such as the brain
connectivity network as previously mentioned [12].
Based on the existing functionalities of the BN/PBN toolbox, we
introduce optPBN, a Matlab-based optimisation toolbox for
probabilistic Boolean networks. optPBN allows for a simple
generation of PBN models from rule-based Boolean modelling.
Prior biological knowledge such as known interactions in the
network, which was not considered in the original BN/PBN
toolbox, can additionally be integrated as inputs in terms of
Boolean rules. optPBN facilitates the incorporation of experimental
data to BN/PBN models in order to generate an integrated
optimisation problem which can subsequently be solved by various
optimisation solvers. In comparison to the BN/PBN toolbox,
optPBN extends the functionality by allowing the identification of
suitable Boolean rules in BNs and the determination of selection
probabilities in PBNs based on experimental data and prior
knowledge. Even though the optimisation pipeline of optPBN is
rather simple and straight-forward, the results generated from
optPBN retain meaningful qualitative and quantitative biological
interpretations which are in accordance with the observed
biological phenomena as captured in the experimental data.
In terms of functionality, optPBN can handle optimisation
problems of networks characterised by various complexities. We
offer a stand-alone version of optPBN toolbox which is suitable for
solving simple optimisation problems, e.g., for small networks. For
solving optimisation problems of complex biological networks such
as the Boolean model of apoptosis from Schlatter et al. which
comprises 86 nodes and 125 interactions [4], we also offer a grid-
based optimisation pipeline of optPBN toolbox that operates on a
large-scale computational platform such as the Grid’5000 [21].
Based on the results obtained from the optimisation of Schlatter’s
model in the PBN format, we quantitatively identified an inverse
correlation between UVB irradiation, nuclear factor kappa-B
(NFkB) and Caspase 3 activations, and apoptotic activity which
could not be demonstrated in the original article due to the
qualitative limitation of the Boolean network framework. In
addition, we were able to estimate the relevancy of a newly
introduced molecular interaction, i.e., the activation of NFkB by
Caspase 8, by considering the value of fitted parameter sets and
the sensitivity of parameters as indicated by parameter distribu-
tions.
Method and Implementation
Probabilistic Boolean networks
A probabilistic Boolean network (PBN) is a collection of Boolean
networks in which a constituent network governs the state (activity)
of a node (molecule) for a random period of time before another
randomly chosen constituent network takes over [7]. Formally, a
probabilistic Boolean network G(V ,F ) is defined by a set of
binary-valued nodes V~fx1,x2, . . . ,xng and a family of sets
F~fF1,F2, . . . ,Fng. For each i~1,2, . . . ,n the set Fi is
Fi~ff (i)1 ,f (i)2 , . . . ,f (i)l(i)g where f (i)j (1ƒjƒl(i)) is a possible Boolean
predictor function for the node xi and l(i) is the number of such
predictor functions. A realisation of the PBN at a given instant of
time is determined by a vector of predictor functions, where the ith
element of that vector contains the function selected at that time
point for xi. For a PBN with N realisations there are N possible
network transition functions f1, f2, . . . , fN of the form
fl~ff (1)l1 , f
(2)
l2
, . . . , f (n)ln g, l~1,2, . . . ,N, 1ƒljƒl(j), f
(i)
lj
[Fj and
j~1,2, . . . ,n. Each network transition function fl defines a
constituent Boolean network of the PBN. In this way the
realisations of the PBN can be identified with the constituent
Boolean networks.
Let c
(i)
j be the probability that the predictor f
(i)
j , 1ƒjƒl(i),
which is selected to determine the value of xi at the next time
instance. It follows that
Pl(i)
j~1 c
(i)
j ~1. The PBN is said to be
independent if the predictors for all nodes are selected independently
of each other. Assuming independence, there are N~Pni~1 l(i)
constituent Boolean networks of the PBN and the probability
governing the selection of a particular network is given by
Pr(fl)~cl~P
n
i~1 c
(i)
li
for all 1ƒlƒN. Two selection schemes are
possible: the selection of the constituent Boolean network takes
place at each consecutive time step (instantaneously random PBN)
or there is a random variable which governs whether the PBN is
updated in accordance with the current Boolean network or a
newly selected one (context-sensitive PBN). In both cases the
constituent network is chosen according to the selection probabil-
ities cj , 1ƒjƒN . For further details on PBN, we refer to [6,7]
which give a comprehensive overview on probabilistic Boolean
networks. An example of a PBN with three nodes is given in
Figure 1.
The example model consists of three nodes V= (N1,N2,N3) and
the functional classes F1= {f
(N1)
1 }, F2= {f
(N2)
1 }, and
F3= {f
(N3)
1 ,f
(N3)
2 }. N1 and N2 are inputs, where N1 activates
N3 while N2 partly inhibits N3 (40%). The respective truth table is
shown in Figure 1C. Once both N1 and N2 are activated (taking a
state value of 1), node N3 could either solely be under the
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influence of N1 with a probability of 0.6, resulting in the activation
of N3 that will take a state value of 1. Or, node N3 could also be
under the influence of both N1 and N2 with a probability of 0.4,
resulting in the inhibition of N3 that will take a state value of 0.
The probabilistic terms that correspond to the selection probabil-
ities (c
(i)
j ) for the Boolean predictor functions are indicated in the
truth table. We study this example in the context of instanta-
neously random PBNs and show three exemplary model
simulations in Figure 1D.
There are two constituent Boolean networks of the example
model given by the two different Boolean rules for node N3 shown
in Figure 1B. These two constituent networks are randomly chosen
at each time step of a simulation which for N1=N2=1 results in
flips of the state value of N3 between 0 and 1 as shown in
Figure 1D.
The dynamics of the PBN is governed by a Markov chain which
structure is presented in Figure 2. The nodes represent the states of
the system and the possible transitions between the states are
labelled with the respective transition probabilities. The graph of
the Markov chain consists of four disjoint parts referred to as A, B,
C, and D, respectively. There are four bottom strongly connected
components of the graph that correspond to four irreducible
subchains of the Markov chain: 000 (part A), 010 (part B), 101
(part C) and 110, 111 (part D). It follows that the Markov chain is
not ergodic.
With N1 and N2 set to 1, the dynamics of the resulting PBN is
given by part D of the Markov chain in Figure 2D which in fact is
an ergodic two-state Markov chain. The steady-state probability
for N3 to be active is 0.6. This value can be estimated by taking
the mean activity over a Monte-Carlo run as shown in Figure 1D.
The respective values obtained for 3 independent runs are 0.57,
0.62 and 0.52. In general, longer runs would result in a better
estimation of the steady-state probability value.
From a biological point of view, the steady-state probability of a
node being active can be interpreted as mean activity of the
respective molecule in a cell population normalised to the maximal
observed value. Let us assume that some a priori knowledge on the
model structure is given in the form of a set of constituent Boolean
networks, but the selection probabilities are unknown. The above
biological interpretation provides basis for considering inferring
the selection probabilities from measurement data from different
biological conditions (e.g., different ligand stimulations, mutants,
or inhibitor treatments). Once selection probabilities are inferred,
the relevancy of Boolean interactions can be determined by the
values of selection probability and the parameters sensitivity as
indicated by their distribution. Furthermore, selection probabilities
can be further used to calculate the influences, which reflect the
relative importance of parent molecules on the target molecules in
the resulting PBN [8].
optPBN pipeline
optPBN is a Matlab-based toolbox which operates under the
framework of the BN/PBN toolbox by La¨hdesma¨ki and Shmulevich
[20], see File S1 for the toolbox and File S2 for optPBN’s examples.
optPBN extends the existing functionalities of the original toolbox
by allowing 1) for an easy BN/PBN models generation procedure
allowing to incorporate prior knowledge, 2) for improved model
fitting to multiple experimental data, i.e., the optimisation of
selection probabilities for different experimental settings, 3) for a
subsequent statistical analysis of the optimised parameters, and 4)
for a fast computation on grid-based platforms. A simplified
pipeline of the optimisation process in optPBN is shown in Figure 3
and a detailed explanation of the pipeline and computational
scripts can be found in File S3.
The optPBN pipeline starts with the generation of a BN/PBN
model from a preliminary model structure which is usually derived
from literature. This step can be easily done by assigning different
Figure 1. An example model with the corresponding Boolean rules, truth table and model simulation results. [A] The example model
consists of 3 nodes with one activation edge and one partial inhibition edge. The weights of both edges are expressed as selection probability next to
the arrow. [B] Two representative Boolean rules were assigned with the corresponding selection probabilities (c(i)j ) to represent the example model in
PBN format. [C] The truth table of the example model demonstrates the state values according to different inputs. Once both inputs (N1 and N2) are
active, the output (N3) has a probability of being ON at 0.6 and of being OFF at 0.4 according to the selection probability of Boolean rules. [D] Three
separated Monte-Carlo simulations were performed on an instantaneously random PBN of the example model in Figure 1. The state values of N3 are
shown on the y-axis as a function of time. The mean of the N3 state values over 20 time steps is given on the upper right corner of each run.
doi:10.1371/journal.pone.0098001.g001
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Boolean interactions in a rule-based Boolean modelling format for
each molecule. This means, prior information is considered in
terms of a set of possible constituent Boolean functions. For each
molecule in a network, single or multiple Boolean functions with
the corresponding selection probabilities can be assigned to define
how often the respective Boolean function will be present in the
chosen constituent network. For unknown or uncertain interac-
tion(s), the selection probabilities of these Boolean rules can be
inferred later by optimisation to normalised experimental data.
In the next step, an optimisation problem is generated based on
the integration of the preliminary BN/PBN model structure and
experimental data. The description of each experimental condi-
tion (e.g., different ligand stimulations, mutants, or inhibitor
treatments) with its respective measurement data are defined as
separate modelling cases. The integration step is simplified by
applying the script rule2PBN to convert the rules and experimental
description of each modelling case into the BN/PBN toolbox’s
internal variables (see the documentation in [20] or File S3) and by
subsequently applying the script add2estim to collect and combine
multiple modelling cases into a single global data structure named
estim. Following this step, the script preprocessMultiExp derives only
essential information to generate a final integrated optimisation
problem which can subsequently be solved by different optimisa-
tion algorithms.
optPBN can be operated in two optimisation modes: ‘discrete’
and ‘continuous’. In the ‘discrete’ mode each Boolean network
from the pool of considered networks is assigned one of two
possible values: 0 or 1. Only Boolean networks with value 1 are
considered as constitutive Boolean networks of the inferred PBN,
each with equal selection probability. In the ‘continuous’ mode the
selection probabilities can be any numbers in the range from 0 to 1
with the only constraint that the sum of selection probabilities of
all constitutive Boolean networks of the inferred PBN is 1.
Additional details on the two optimisation modes can be found in
File S3.
To solve the integrated optimisation problem, two different sets
of optimisers are used in optPBN: 1) particle swarm optimisation
(PSO), pswarmSB [22], a global optimisation algorithm as described
in the Systems Biology Toolbox 2 (SBToolbox2) [23,24], and 2) the
evolutionary algorithm (EA) [25] which is integrated in the
population-based meta-heuristic optimisation framework Paradi-
sEO [26] coupled with a differential evolution algorithm (DE) [27].
We therefore offer two versions of optPBN: a stand-alone version
which uses pswarmSB and a grid-based version which uses the
coupled EA and DE algorithms. For additional details on the
pipeline of the grid-based version and the algorithms used, please
see File S4.
The stand-alone version of the optPBN toolbox (PSO-based) was
designed for solving simple optimisation problems, e.g., for small
networks, while the grid-based version (EA- and DE- based) was
customised to be implemented on a large-scale computational
platform such as the Grid’5000 [21] for solving complex
optimisation problems. The respective objective function of the
optimisation process in optPBN pipeline is to minimise the sum of
squared errors (SSE) between 1) molecular activities as represented
Figure 2. Structure of the dynamics of the example model. The
dynamics of the example PBN model presented in Figure 1 is governed
by a Markov chain. The graph of the Markov chain consists of four
disjoint parts as presented in [A], [B], [C], and [D], respectively. In each
graph, the nodes represent the states of the system and the possible
transitions between the states are labelled with the respective
transition probabilities. Four bottom strongly connected components
of the graph that correspond to four irreducible subchains of the
Markov chain are shown as follows: 000 [A], 010 [B], 101 [C] and 110,
111 [D].
doi:10.1371/journal.pone.0098001.g002
Figure 3. Optimisation pipeline of the optPBN toolbox. A
preliminary model structure is required as an input for the generation
of a PBN model. The generated PBN models from different experimental
conditions together with the corresponding measurement data are
subsequently combined to generate an integrated optimisation
problem which can be solved by various optimisation algorithms. Once
the optimisation algorithm(s) generate sufficient amount of good
parameter sets, a statistical analysis of the optimised parameter sets
(i.e., of PBN’s selection probabilities) is performed to indicate the
identifiability and the sensitivity of parameters through the consider-
ation on parameters’ distribution. The optPBN scripts used for each task
are given in parentheses.
doi:10.1371/journal.pone.0098001.g003
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by their steady-state probabilities and 2) measurement data in each
experimental condition. The interface for communication between
the integrated optimisation problem in BN/PBN toolbox’s internal
format and the optimisers, e.g., the conversion from sampled
parameter values to selection probabilities (c
(i)
j ) in PBN, is provided
in the script optfun with a set of adjustable parameters to customise
the optimisation process (see File S3).
During the optimisation process, we approximate the marginal
steady-state distribution of the output nodes by applying the two-
state Markov chain method as presented in the study of
Shmulevich et al. [28]. The ergodicity of the PBN’s underlying
Markov chain is ensured by the introduction of perturbations
controlled by a small perturbation parameter (p) as introduced by
Miranda and Parga [29]. The two-state Markov chain method is
subsequently applied to determine the number of simulation steps
to be discarded before reaching steady-state (‘burn-in period’, m0)
and the minimal number of time steps (N) required to estimate the
marginalised steady-state distribution at a pre-defined accuracy.
The accuracy of the steady-state approximation can be adapted by
adjusting the parameters (e, r, and s) as described by Raftery and
Lewis [30]. Note that the equations used for the calculation of m0
and N as presented in [28] and [30] contain two small errors. We
present the correct derivations of these two-state Markov chain
approach formulas in File S5 and we applied the correct formulas
in the optPBN pipeline accordingly.
Starting from an initial parameters setting (e.g. m0 = 0 and
N=100), we iteratively determine a new pair of values for m0 and
N from the estimated transition probabilities between the two
meta-states. If the new value for m0+N is greater than the previous
value, the model is simulated further in order to extend the
trajectory to the length given by the new value of m0+N. Then, the
transition probabilities are re-estimated from the last N states in
the trajectory and used to calculate new values for m0 and N. This
process is repeated until the new value for m0+N is not greater than
its previous value. Finally, the marginalised steady-state probabil-
ity is estimated with the frequency with which the corresponding
state in the two-state Markov chain was sampled within the N last
elements of the obtained trajectory.
We observed in the investigated case studies that at least 5,000
iterations of selection probability (c
(i)
j ) parameter sampling by
optimisers for small models (n,10) and at least 7,500 iterations for
large model (10,n,100) are sufficient to get a good fit and to
obtain representative parameter sets for further statistical analysis.
Note that this only holds for the investigated examples and cannot
be generalised for other large-scale models. Once the optimisation
process is finished, the best parameter set is reported and the
model can be re-simulated with the script evalCijAndSimulate in
order to check the quality of model fitting by comparing simulated
steady-state probability to measurement data (see detailed
explanation in File S3). Note that under the stochastic events of
constituent networks chosen during PBN simulations, the same
exact result might not be observed from the re-simulation.
Nevertheless, the differences of the results between each simulation
are expected to be minimal based on the assumption that the
approximation of the steady-state distribution with the two-state
Markov chain approach is rather accurate.
After checking model fitting, a representative set of parameters
which fit well to measurement data can be chosen for further
statistical analysis. The calculation of mean and standard deviation
(SD) of the selected set of parameters can be performed by
applying the script BestRunsStat. The mean of selection probabil-
ities from selected parameter sets indicates to some extent what are
the expected selection probabilities for the potential constitutive
Boolean networks in PBNs that fit the experimental data. In
parallel, the SD value gives an insight on the identifiability for each
parameter and parameters’ sensitivity can be assessed from
parameter distributions. These pieces of information in turn allow
for the estimation of the relevancy of Boolean interactions within
the context of the study.
Results and Discussion
In this section, four case studies with different levels of
complexity are presented to demonstrate the functionalities of
optPBN. We applied the optPBN pipeline, which approximates
marginalised steady-state distribution with simulation of ergodic
PBNs coupled with the two-state Markov chain method, to
generate the results in this section. The parameters for checking
steady-state convergence are set as follows: p= 0.001, r = 0.025,
e=0.01 and s = 0.95.
For each case study, we consider the best 500 parameter sets in
terms of the optimal cost to analyse the identifiability of the model
parameters and to perform subsequent statistical analyses. The
spread of the identified parameters for each case study is shown in
Figure 4. The scatter plots show that the obtained parameters are
clustered for the first three case studies. However, the parameters
in case study 4 are not always clustered. Therefore, we
demonstrated the result generated from the best run of each case
study which was marked as a red asterisk on Figure 4. A summary
of these results can be found in File S6.
Case study 1: optPBN allows for the identification of
suitable Boolean rule(s) in Boolean networks
With respect to optimising qualitative Boolean networks, optPBN
is capable of identifying a set of suitable Boolean rules from a user-
defined list of candidate rules based on experimental data. For this
task, optPBN is operated in the ‘discrete mode’ for which only 0
and 1 values for the selection probabilities are evaluated (see detail
in File S3).
In order to demonstrate the respective functionality of optPBN,
we use case study 1 (Figure 5) as an example. We pre-define a set
of five different Boolean rules to represent the potential influence
of PI3K and TNFa on NFkB as follows: connect PI3K and TNFa
activation with an OR gate (|), connect PI3K and TNFa
activation with an AND gate (&), has only an activation from
PI3K (PI), has only an activation from TNFa (TN), and has no
interactions from either PI3K or TNFa and output is fixed to 0
(Ø). We consider 4 experimental measurements of NFkB, each
with a configuration of the input nodes PI3K and TNFa. For each
individual measurement, we applied optPBN to determine which of
the pre-selected rules(s) is capable of explaining the experimental
data. The obtained results show that optPBN could identify the
correct Boolean rules. Then, we applied optPBN to all experimen-
tal measurements considered simultaneously. In this case, optPBN
identified the connection of PI3K and TNFa to NFkB with an
AND gate (&) as the only suitable Boolean rule which can explain
the complete set of experimental data. This case study shows that
optPBN can be applied for the inference of biological networks in
the Boolean formalism. The obtained results are summarised in
Table 1.
Case study 2: optPBN allows for the determination of
selection probabilities in probabilistic Boolean networks
In this theoretical case study, we consider the regulation of PIP3
by PI3Kand PTEN. We assume that this process can be modelled
with the network presented in Figure 1A, where the nodes N1, N2,
and N3 represent PI3K, PTEN, and PIP3, respectively. Nodes N1
Optimising Probabilistic Boolean Networks
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and N2 are the so-called input nodes, i.e., they are not influenced
by any node in the network and their values are determined by
explicit assignment. This makes that the underlying Markov chain
consists of four disjoint, non-communicating Markov subchains,
one for each of the four different assignments of values to the input
nodes.
Let us now assume that the model structure is only partially
known, i.e., it is known that PI3K activates PIP3, but there is no
certain information on whether PTEN activates or inhibits PIP3
and to what extent. Therefore, as a prior knowledge, we consider
four different Boolean rules that encode four potential signal flows
from PI3K and PTEN to PIP3 as follows: only activation from
PI3K (PI), only activation from PTEN (PT), activation from PI3K
and inhibition from PTEN (PI&,PT), and no interaction from
either PI3K or PTEN and output is 0 (Ø). Furthermore, four
experiments are performed, where various combinations of values
for PI3K and PTEN as the initial conditions are considered. As the
measured values of PIP3 we take the theoretical values of the
Figure 4. Scatter plots of a set of fitted parameters from all case studies. The distributions of selection probabilities from the best 500
parameter sets in term of optimal cost are shown in [A] for case study 1 (node NFkB), [B] for case study 2 (node PIP3). The dependency among
selection probabilities across two nodes are shown in [C] for case study 3 (nodes NFkB and ERK) and [D] for case study 4 (nodes NFkB and complex2).
The parameter values for the first 3 case studies form a single cluster which indicates that the respective parameters are identifiable. However, the
parameter which influences on NFkB (y-axis) seem to be identifiable in case study 4 but the parameter which influences on complex2 (x-axis) are
much sparser. Such observation raises an issue in term of parameters’ identifiability. Only the best parameter set from each case study (marked as a
red asterisk) was therefore used for further analysis and interpretation.
doi:10.1371/journal.pone.0098001.g004
Figure 5. Case study 1. [A] Case study 1 deals with a Boolean
network that consists of 3 nodes with an unknown Boolean interaction
from the two inputs. [B] The table contains artificial experimental data
from four different combinations of input states (Experiments ‘A’, ‘B’, ‘C’,
and ‘D’) of case study 1.
doi:10.1371/journal.pone.0098001.g005
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underlying Markov chain stationary probabilities determined by
the initial conditions. The partially known network structure and
the experimental data are shown in Figure 6. Now, we applied
optPBN to perform the optimisation in the ‘continuous mode’
where an extensive continuous parameter space (the interval from
0 to 1) is explored within the optimisation process to determine the
selection probabilities for the four different Boolean rules.
When performing optimisation, the values of the input nodes
are fixed to the values specified by the available experimental
conditions, one by one. For each experimental dataset only the
subchain determined by the experimental condition is considered.
In order to make the considered part of the underlying Markov
chain ergodic, perturbations are introduced which make the
considered subchain irreducible and aperiodic. In this way, the
considered part has a unique steady-state probability distribution
which can be estimated by the two-state Markov chain approach
independently of the choice of the initial state of a simulation. The
obtained steady-state probabilities are estimated and the squared
difference of the estimated value and the experimental value is
calculated. To get the final fit score, the squared differences from
all experimental conditions are added.
Two remarks are in place. First, it should be noted that the fit
quality of these experiments could be improved by increasing the
accuracy for the approximation of steady-state distribution, e.g.,
by adjusting the parameter ‘r’. Details on model fitting’s quality in
relationship to the accuracy parameter ‘r’ can be found in File S6.
Second, more importantly, the inference results heavily depend on
the experimental data. In this case study the set of experimental
data was comprehensive in the sense that it covered possible
assignments of values to the input nodes: by considering
experiments A, B, C, and D in Figure 6 part [B], all the four
non-communicating subchains of the Markov chain in Figure 2
are taken into account. If this is not the case, the inference may
result in wrong outcomes. According to the results of this case
study shown in Table 2, the selection probabilities inferred from all
experiments agree well with the selection probabilities of the
original network. However, when only experimental data from
experiments A and D were taken into account, the optimisation
inferred a PBN consisting of all four constituent Boolean networks
given by the rules ‘PI’, ‘PT’, ‘PI&,PT’,and ‘Ø’, with selection
probabilities 0.4602, 0.1344, 0.3607 and 0.0447, respectively.
In summary, this case study demonstrates that the optPBN
toolbox can be applied to infer selection probabilities from given
comprehensive data. Once the selection probabilities are obtained,
they can subsequently be used to estimate the relevancy of Boolean
interactions. In addition, they can also be used to determine the
influence between molecules as presented in [8].
Case study 3: optPBN generates comparable results to an
existing tool while having a broader functionality
To date, there are several computational tools which are
applicable for the optimisation of biological networks in the
Boolean formalism. One of the leading tools is CellNetOptimizer
(CellNOpt a.k.a. CNO) introduced by Saez-Rodriguez et al. [17].
CellNOpt was applied for building logic-based models of signal
transduction networks in different logic formalisms that are trained
against high-throughput proteomics data [18].
To illustrate and prove the functionalities of CellNOpt, the tool
was used to optimise a toy model based on a set of artificial
experimental data. The objective function of CellNOpt is based on
two components: 1) the mean squared error (MSE) deviation
between data and predicted states, and 2) a penalised term for
increasing model size (E`s) which is adjustable by a scaling factor
(a). By minimising a combination of these two terms, CellNOpt was
able to identify the Boolean interactions that correspond to
experimental data (see Figure S1).
To benchmark our newly developed toolbox, we applied optPBN
to optimise the compressed version of the toy model in Boolean
Table 1. Results from the optPBN toolbox for case study 1 compared to the original network.
Optimisation results
Exp|rules I & PI TN Ø
A 3 (0.2) 3 (0.2) 3 (0.2) 3 (0.2) 3 (0.2)
B 7 (0) 3 (0.33) 7 (0) 3 (0.33) 3 (0.33)
C 7 (0) 3 (0.33) 3 (0.33) 7 (0) 3 (0.33)
D 3 (0.25) 3 (0.25) 3 (0.25) 3 (0.25) 7 (0)
All (A to D) 7 (0) 3 (1) 7 (0) 7 (0) 7 (0)
Original network
Correct rule 7 (0) 3 (1) 7 (0) 7 (0) 7 (0)
The table shows the results of optimisation for four different individual datasets (A, B, C and D) and for the combined four datasets (All) compared to the original
network. Five different Boolean rules are applied as follows: connect PI3K and TNFa activation with an OR gate (|), connect PI3K and TNFa activation with an AND gate
(&), has only an activation from PI3K (PI), has only an activation from TNFa (TN), and has no interactions from either PI3K or TNFa and output is fixed to 0 (Ø). The symbol
‘3’ indicates that the respective rule can explain the measurement data while the symbol ‘7’ refers to the contrast observation. The results from the optPBN toolbox
divide the sum of probabilities, i.e. 1, by the number of correct result(s) in each experiment (given in parentheses) and they all correspond to the correct results.
doi:10.1371/journal.pone.0098001.t001
Figure 6. Case study 2. [A] Case study 2 deals with a probabilistic
Boolean network that consists of 3 nodes with an unknown type and
weight of interaction from PTEN to PIP3. [B] The table contains artificial
experimental data from four different combinations of input states
(Experiments ‘A’, ‘B’, ‘C’, and ‘D’) of case study 2.
doi:10.1371/journal.pone.0098001.g006
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formalism as presented in the original CellNOpt article [18], see also
Figure S1. The original toy model comprises 8 nodes. There are 2
input nodes which are TGFa and TNFa with two downstream
nodes that can be inhibited by inhibitors (PI3Ki and Rafi). The
presence of inhibitor is depicted in the input table with ‘2’ once it
is absent and with ‘+’ when it is present. The rest of the nodes are
considered as output nodes and are all measured. Here, we applied
optPBN to optimise the two unknown logic gates for NFkB and
ERK.
The original model structure with 6 different experimental
conditions were plugged into the optPBN pipeline in ‘discrete
mode’ as previously described for case study 1. optPBN is capable
of acquiring the same results as CellNOpt, i.e. to identify
‘NFkB=PI3K & TNFa’ and ‘ERK=Raf’ as the correct Boolean
rules. In addition, optPBN also identified the rule ‘ERK= -
Raf|NFkB’ as an additional solution that can also explain the
data from all experimental conditions (see Figure S1). We also
verified that both correct Boolean rules are independent as the
optimal costs after assigning these two rules one-at-a-time to be the
correct rule are highly similar.
Then, we extended the current study by applying optPBN for the
optimisation of a modified toy model based on a new set of
artificial data (case study 3) as shown in Figure 7. In this version,
we assumed that the weights of molecular activation and the
inhibitors’ efficacies are not absolute, resulting in a propagation of
signals in a non-discrete (continuous) manner. Once output nodes
can be activated by multiple molecules, i.e., NFkB can be activated
by PI3K and TNFa while ERK can be activated by Raf and
NFkB, we consider disjoint activating signals from both inputs
which are sum up to a full activation. When inhibitor is
additionally present, the activating signal is reduced proportionally
to the inhibitor’s efficacy.
Considering e.g. experiment D, both inputs are ON and there
are two unknown weights of activation from PI3K and TNFa
towards NFkB with the presence of PI3K-inhibitor treatment. If
we assume that the activating signal from PI3K is 70% and from
TNFa is 30% with the presence of PI3K-inhibitor that inhibits
PI3K signal at 70%, the signal for the activation on NFkB in this
experiment can be calculated from the sum of the remaining PI3K
signal after inhibition (100%270%=30%) multiplied by the
weight of PI3K’s activation (70%), resulted in the signal value of
0.3*0.7 = 0.21. This signal is then combined with the disjoint
activating signal from TNFa (30% or 0.3). The sum of activating
signals for NFkB node is therefore 0.51 in this experimental
setting.
To perform an optimisation study on this modified toy model,
optPBN was applied in the ‘continuous mode’ as previously
described for case study 2. The optimisation results as shown in
Table 3 are in a good agreement with the selection probabilities of
the original model.
In summary, the results from the two toy model studies
demonstrate that the optimised networks generated from CellNOpt
and optPBN are similar when operated in a discrete (qualitative)
optimisation mode. At the same time, optPBN offers an additional
functionality of a continuous (quantitative) optimisation mode to
identify selection probabilities which might yield additional insight
into the relevancy of interactions within the network.
Case study 4: optPBN allows for the optimisation of an
apoptotic network at scalable computational time and
for the estimation of interactions’ relevancy in a context-
specific manner
Optimisation of an apoptotic network in the PBN
framework. Schlatter et al. introduced a large-scale Boolean
network of apoptosis in hepatocytes that consists of 86 nodes and
125 interactions as shown in Figure 8. [4] The assigned Boolean
interaction for each molecule was derived from literature. After
the Boolean model was built, it was subsequently validated by
experimental data which were categorised into three discrete
values: no activity ‘0’, low activity ‘1’, and high activity ‘2’. The
analysis of Schlatter’s model was conducted in CellNetAnalyzer
(CNA), a Boolean network and constraint-based models analyser
which allows for the calculation of logical steady-states [31]. As the
original model structure comprises many feedback loops, 13
interactions were removed from the model in order to generate a
new model variant which delivers fixed point steady-states and
thus is compatible to be analysed in CNA. The analysis revealed
the effects from different cytokines stimulations and UVB
irradiations towards apoptosis in hepatocytes, but only in a limited
qualitative manner [4].
Based on the original study, we applied optPBN to optimise
Schlatter’s model in the PBN formalism. We converted the multi-
value Boolean model of apoptosis into a binary PBN model which
comprises 96 nodes and 106 interaction functions (‘initial apoptosis
model’). We used the selected set of Boolean interactions as
described in the original article with minimal modifications on a
few Boolean rules to make them suitable for modelling in the PBN
format (see File S2). Our initial aim is to optimise selection
probabilities of our PBN model in order to return the steady-state
probabilities of 3 output nodes, i.e., Apoptosis, Caspase 3 and
Table 2. Results from the optPBN toolbox for case study 2 compared to the original network.
Optimisation results
Exp|rules PI PT PI&,PT Ø
A,D 0.4602 0.1344 0.3607 0.0447
All (A to D) 0.6041 0 0.3959 0
Original network
Selection probabilities 0.6 0 0.4 0
The table shows the results of optimisation for two datasets: 1) containing measurement data from experiments A and D 2) containing all measurement data from
experiments A, B, C and D. Four different Boolean rules are applied as follows: only activation from PI3K (PI), only activation from PTEN (PT), activation from PI3K and
inhibition from PTEN (PI&,PT), and no interaction from either PI3K or PTEN and output is fixed to 0 (Ø). The selection probabilities inferred from all experiments agree
well with the selection probabilities of the original network. The dataset consisting of the measurement from only experiments A and D is insufficient to reconstruct the
original network.
doi:10.1371/journal.pone.0098001.t002
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NFkB, which match the measurement data. We optimised the
selection probabilities of Boolean rules for 7 target nodes: IKK,
IkBa, IkBe, complex2, caspase8 and caspase3 (both at low and
high activities), which are connected to the 3 output nodes. This
results in the optimisation of 17 selection probabilities.
Next, pre-processing of the original measurement data on
hepatocytes for the three output nodes: Apoptosis, Caspase 3 and
NFkB, was performed by background subtraction and normalisa-
tion to the maximal value. Saturation of Caspase 3’s signals was
assumed in our study (see File S7). Then, the normalised
experimental data and the PBN model description were combined
into an integrated optimisation problem which was subsequently
solved with optPBN in ‘continuous mode’.
For this case study six different experimental conditions which
were experimentally validated are given. During optimisation six
subchains of the underlying Markov chain are considered, each
determined by fixing an input node’s value in accordance with the
experimental condition. The fixed value of the input node is not
perturbed, but all the other nodes can be perturbed, which makes
the subchain ergodic and in consequence having a unique steady-
state distribution. It should be noted that performing the
optimisation with use of a more rich set of experimental data,
i.e., for conditions which correspond to setting the input nodes to
different combinations of values, could provide more insight into
the network interactions.
Optimisation of a complex network at scalable
computational time. To evaluate the fitting cost during the
optimisation process, the marginalised steady-state probabilities
for activity of one molecule at a time for a set of output nodes
(Apoptosis, Caspase 3 and NFkB) needed to be estimated. As
previously presented in the description of the optPBN pipeline, this
was achieved by applying the two-state Markov chain approach
with the accuracy set to 0.025 (r = 0.025). Although the size of the
underlying Markov chain of the PBN is huge, i.e., 296 states, it
Figure 7. Modified toy model of Saez-Rodriguez et al. and corresponding artificial experimental data (case study 3). [A] The modified
toy model from Saez-Rodriguez et al. [18] is a probabilistic Boolean network that consists of 8 nodes with two unknown weights of Boolean
interactions for NFkB and ERK. [B] The table describes the states of inputs and inhibitor treatments for 6 experimental conditions. [C] The
corresponding normalised artificial experimental data of the experimental conditions as described in [B]. The 6 experimental conditions based on the
combination of stimulus and inhibitor treatments yield different readouts on four downstream molecules.
doi:10.1371/journal.pone.0098001.g007
Table 3. Results from the optPBN toolbox for case study 3 compared to the original network.
Optimisation results
Outputs NFkB ERK
Exp|rules PI TN RA NF
All (A to F) 0.708 0.292 0.603 0.397
Original network
Selection probabilities 0.7 0.3 0.6 0.4
The table shows the optimisation results for the dataset which combines all six experiments from A to F (All) in case study 3. Two different Boolean rules are applied for
NFkB and another two rules for ERK as follows: activation signal from PI3K (PI) or TNFa (TN) to NFkB, and activation signal from Raf (RA) or NFkB (NF) to ERK. The results
from the optimisation of modified toy model from Saez-Rodriguez et al. are corresponded with the correct results.
doi:10.1371/journal.pone.0098001.t003
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Figure 8. Boolean model of apoptosis by Schlatter et al. and normalised experimental data (case study 4). [A] The Boolean model of
apoptosis by Schlatter et al. [4] consists of 86 nodes with 125 Boolean interactions. The model was analysed with CellNetAnalyzer (CNA) to study the
correlations between 10 different inputs from different cytokines stimulations and UVB irradiations towards apoptosis. [B] The normalised
experimental dataset were generated based on the experimental data as presented in the original article (see details in File S7). The inverse
correlation between UVB irradiation, NFkB and P17 form of activated Caspase 3 (C3ap17) activations, and apoptotic activity is quantitatively observed
in the original measurement data.
doi:10.1371/journal.pone.0098001.g008
Table 4. Run-time analysis of grid-based optPBN pipeline.
Model Iterations Stand-alone version (1 core) Grid-based version (80 cores) Improvement (folds)
1 1000 305s (5m5s) 8s 38.1
5000 1093s (18m13s) 16s 68.3
2 1000 321s (5m21s) 9s 35.7
5000 1205s (20m5s) 16s 75.3
3 (modified model) 1000 1302s (21m42s) 18s 72.3
5000 6151s (1h42m31s) 39s 157.7
4 (extended structure) 1000 16783s (4h39m43s) 99s (1m39s) 169.5
5000 45503s (12h38m23s) 259s (4m19s) 175.7
The table shows the computational time of the optimisation process required by the grid-based version of optPBN pipeline operated on 80 cluster cores in comparison
to the one required by the stand-alone version running on a single local machine. The run-time analysis was performed on the four case studies for 1,000 and 5,000
parameter samplings to approximate the steady-state probability distribution of output nodes. The results reveal a remarkable reduction of the computational time
from 35 to 175 folds. Abbreviations: s = seconds, m=minutes, and h = hours.
doi:10.1371/journal.pone.0098001.t004
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turned out that in all three cases (Apoptosis, Caspase 3 and NFkB)
the two-state Markov chains were well-mixing: there were frequent
transitions between the two meta-states of the two-state Markov
chains that were considered on top of the underlying Markov
chain of 296 states. In consequence, the marginalised probabilities
could be estimated from trajectories of length less than 4000 (see
File S6). Given this, we were able to perform the optimisation task
in a feasible amount of computational time.
To confirm the accuracy of our results, we performed additional
analyses by fixing one set of selection probabilities (randomly
generated) and started the simulation from random initial
conditions as well as from the extreme cases where initial
conditions for all nodes are either zero or one. We found that
the variations between these 3 cases are minimal, all less than 0.01
(1%). Also, we generated another set of results with higher
accuracy (r = 0.01) where the number of required time steps is
increased approximately 6 folds. We found that the steady-state
distributions of output nodes which were estimated at the two
levels of accuracy (r = 0.025 and r = 0.01) are almost the same, i.e.,
they differ by less than 0.01 (1%) in all case. This indicates that the
chosen parameters lead to a good estimate of the steady-state
distribution of the considered model. We also performed the same
analysis multiple times for different parameter sets where we
obtained similar results. We present a comprehensive datasheet of
the analysis performed for one parameter set in File S8.
Due to the large size of the apoptotic network (Figure 8), the
stand-alone version of optPBN pipeline which runs on a standard
local computer (1 CPU Intel@2.99 GHz, 2 cores/CPU, 3.25 GB
RAM) is not suitable to solve the optimisation problem. Since the
optimisation required 12 hours of computational time to evaluate
approximately 5,000 parameter samples on a standard computer,
we applied the grid-based version of optPBN to solve this
optimisation problem on the Grid’5000 using 10 server machines
(1 server machine comprises 2 CPUs Intel@1.995 GHz, 4 cores/
CPU, 15 GB RAM, see detailed documentation on the installation
and execution of the grid-based pipeline in File S4 and File S9).
The optimisation process was operated in the ‘continuous mode’
on 80 parallel processing cores where the results were delivered in
a timely manner (approximately 10 minutes to evaluate 15,000
parameter samples). The run-time analysis of four case studies
reveals a reduction of computational time from 35 to 175 folds
when running the same optimisation tasks on Grid’5000 with 80
cores. More details on this analysis are shown in Table 4.
Approximation of steady-state distributions by optPBN
reveals more quantitative insight into biological data. For
comparison, the original results from Schlatter’s study (Orig.) and
the set of results from the optimisation of the ‘initial apoptosis
model’ by optPBN (Init.) are shown in Table 5. We were able to
identify a PBN model structure with a set of selection probabilities
that could match relatively well to the measurement data
quantitatively, while the results from the original model are only
limited to 0 and 1 value. The fitting costs of the original model and
of the ‘initial apoptosis model’ based on the calculation of SSE are
1.002 and 0.328, respectively. This indicates that the apoptosis
model in the PBN formalism fits the measurement data better.
In addition, the inverse correlation between the intensity of
UVB irradiation, the activations of NFkB and Caspase 3, and the
apoptotic activity were also identified in a quantitative manner.
Namely, a stronger UVB irradiation (i.e., UV2=600 £/m2.
UV1=300 £/m2) resulted in a stronger NFkB pathway activation
(0.3083 against 0.0023) but a weaker Caspase 3 activation (0.0016
against 0.9966) and a weaker apoptotic activity (0.4681 against
0.9920). In contrast, the original study of Schlatter et al. could only
identify this relationship in a limited qualitative manner [4].
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optPBN allows for an estimation of interactions’
relevancy in a context-specific manner. As can be seen in
Table 5, the fitted ‘initial apoptosis model’ (Init.) failed to explain
some of the experimental data. For instance, the fitting of NFkB in
a condition with a high concentration of Fas ligand stimulation
(FasL (2)) is not in a good agreement with the experimental
measurement (0.0198 against 0.32). This observation raises a
question whether the set of considered molecular interactions was
sufficient to model the context-specific apoptotic signalling in the
hepatocytes.
In fact, NFkB can also be activated through Caspase 8 with a
mechanism distinct from that of tumour necrosis factor alpha
(TNFa) for cytokine production as described in [32,33]. There-
fore, we modified the Boolean rules to take this information into
account and thereby derived a new model called ‘extended
apoptosis model’ (see detail in File S2). The results from the
optimisation on the ‘extended apoptosis model’ (Ext.) are shown in
Table 5. We found that the ‘extended apoptosis model’ fits the
experimental data better (cost of 0.199) than the ‘initial apoptosis
model’ (cost of 0.328) and the inverse correlation between UVB
intensity, NFkB and Caspase 3 activations, and apoptotic activity
is still preserved. In addition, we also found that the discrepancy
between the simulated model state and the measurement data of
NFkB in the FasL (2) experiment is decreased after the addition of
the new molecular interaction derived from literature.
In Figure 4, we presented the best 500 values for selection
probabilities c
(NFkB)
1 and c
(complex2)
1 in term of fitting cost. By taking
1-c
(NFkB)
1 and 1-c
(complex2)
1 , we could determine the values for the
selection probabilities c
(NFkB)
2 and c
(complex2)
2 respectively. The
mean and the SD values for these selection probabilities are given
in Table 6. These statistics were confirmed in 3 independent
optimisation runs with 500 best parameter sets considered in each
run (see File S2).
We found that the selection probability c
(NFkB)
2 for the Boolean
rule which represents the co-influence of Caspase 8 and nuclear
factor of kappa light polypeptide gene enhancer in B-cells inhibitor
alpha and epsilon (IkBa/IkBe) degradations on the activation of
NFkB obtained a mean value of 16% with SD of 2%. The non-
zero mean value indicates that this interaction is important to
explain the experimental data in the context of our study. Also, the
narrow distribution of the values of selection probability for this
Boolean rule suggests that the model is sensitive to this parameter.
Such information therefore highlights the relevancy of this newly
introduced interaction. In contrast, the distribution of the values of
the selection probability c
(complex2)
2 which describes the influence of
deubiquitinated form of receptor associated kinase 1 (RIPdeubi) on
the activation of TNF receptor-1 signalling complex 2 (complex2)
is more spread. This might suggest that the model is less sensitive
to this parameter. Therefore, the relevancy of this interaction in
the context of our study is still in question.
We tried to further investigate the influence of RIPdeubi on
complex2 by following the methodology as presented in [8].
However, we observed that, the required length of the trajectory to
estimate the joint distribution on the parent nodes of complex2 is
very long and therefore it is practically infeasible to perform this
analysis in a reasonable amount of time with the current
implementation of the optPBN toolbox. Thus, we further estimate
the relevancy of this interaction by considering the model topology
within the context of our study instead.
Considering the model topology as presented in [4], the Boolean
interaction in question represents positive signals on the activation
of complex2 by RIPdeubi via two sources (see Figure 8): 1) A
positive feedback loop from activated Caspase 8 (C8*) + unknown
proteins in type 2 apoptosis (P)Rtruncated Bid (tBid)RBaxRS-
macRRIPdeubiRcomplex2RC8*-complex2RC8*, and 2) The
positive signal from UVB radiation (UV)RBaxRsmacRRIPdeu-
biRcomplex2. According to the original study, the activation of
type 2 receptor (T2R) was only considered and experimentally
validated in the context of Jurkat cells, but not hepatocytes [4].
Therefore, the node P which is activated by T2R will never be
activated and the feedback loop as shown in 1) is not active in our
PBN model (which only fits to the hepatocyte data). In parallel, the
activation of complex2 by UVB (via RIPdeubi) requires the
presence of TNF receptor-1 signalling complex 1 (complex1). This
means the positive interaction in 2) will only be valid when TNF and
UVB co-stimulate. Nevertheless, this condition was not validated in
the original study [4] nor was constrained in the PBN model either.
Thus, the interactions on complex2 activation from 1) and 2) via
RIPdeubi as described are not relevant in the context of primary
hepatocyte. These interactions could therefore be removed from the
PBN model in our study.
We demonstrated that optPBN can be applied to determine the
selection probabilities in PBN which can subsequently be used to
estimate the relevancy of molecular interactions in the context of
study. Such information in turn leads to the generation of
computational models which could represent the dynamics of
biological networks in a context-specific manner.
Table 6. The distributions of fitted selection probabilities on the extended apoptosis model.
Molecule Functions Mean SD
NFkB = (,I_kBa|,I_kBe) 0.8354 0.0209
= (,I_kBa|,I_kBe)|(C8a|C8a_2) 0.1646 0.0209
complex2 = complex1 & FADD 0.8480 0.1105
= complex1 & FADD & RIP_deubi 0.1520 0.1105
The Boolean rules of two target molecules in the ‘extended apoptosis model’ and the parameter distributions of the top 500 fitted selection probabilities in terms of
optimal cost are shown. A low standard deviation (SD) value comparing to the corresponding mean value indicates that model is sensitive to the parameter of the
respective Boolean interaction. This information highlights the relevancy of the respective interaction within the context of study e.g., the case of nuclear factor kappa-B
(NkFB) activation by Caspase 8 (C8a or C8a_2) together with the absence of nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor alpha and
epsilon (IkBa and IkBe) inhibitions. In contrast, a high value of standard deviation comparing to the mean value as seen in the case of TNF receptor-1 signalling complex
2 (complex2) activation by deubiquitinated form of receptor associated receptor kinase 1 (RIP_deubi) suggests that the model might not be sensitive to the respective
parameter in this study. The relevancy of this interaction within the context of apoptotic signalling in primary hepatocytes is therefore in question.
doi:10.1371/journal.pone.0098001.t006
Optimising Probabilistic Boolean Networks
PLOS ONE | www.plosone.org 12 July 2014 | Volume 9 | Issue 7 | e98001
Conclusions
We present optPBN, a novel optimisation toolbox which
provides a simple yet comprehensive pipeline for the generation
of integrated optimisation problems in the PBN formalism which
can readily be solved by various optimisers on local or grid
computational platforms. The optPBN toolbox offers two modes of
optimisation, discrete and continuous, for the selection of
appropriate constituent Boolean networks for the PBN from the
pool of available choices and for the determination of selection
probabilities from experimental data, respectively. The two modes
can be applied for the optimisation and/or inference of the
networks in both qualitative and quantitative manner.
optPBN was tested and compared against existing optimisation
tools for the Boolean formalisms where optPBN delivers similar
results and it also offers quantitative optimisation. The updated
version of CellNOpt, CellNOptR, is also capable of handling
quantitative optimisation, but the respective Boolean models have
to be converted into fuzzy logic or ordinary differential equation
(ODE) modelling frameworks beforehand [17,34]. We also
demonstrated that optPBN allows for the optimisation of an
apoptotic network, leading to the generation of an optimised PBN
model with the corresponding selection probabilities that fit
experimental data. Such results do not only yield a better
quantitative insight into biological networks, they can also be
further used to evaluate interactions’ relevancy within the network
in a context-specific manner. Lastly, the computational time which
is a major limitation when dealing with complex optimisation
problems can be better handled by applying the grid-based
implementation of the optPBN optimisation pipeline.
Limitations
Even though optPBN offers many simple-to-use functionalities,
there are some limitations that come along with the simplicity of
the toolbox. First, our approach always requires prior knowledge
on the possible interactions between molecules which are given in
the form of potential constituent Boolean networks. There exist
approaches using Bayesian network with Boolean variables for
reconstructing biological networks which do not have this
limitation, see e.g., [35]. Second, the formulation of the rule-
based modelling has to be in a specific order when there is a
combination between parameter and constant value in the
assignment of different Boolean rules. For instance, given an
output which can be activated by an input (a parameter is assigned
to the rule) while it can also be inhibited by an inhibitor (the
constant value ‘0’ is assigned to the rule), the Boolean rule which
represents the activation by an input has to come first (see more
examples in the help section of the script rule2PBN in the optPBN
toolbox). Lastly, optPBN uses only one global data structure (estim)
to store and process all information of the network so that the
integrated optimisation problem can be solved simultaneously for
all experimental cases. This setting might not be applicable to
solve the optimisation problem where different parameter values
are expected for each experimental case (i.e., the optimisation of
local parameters). The optimisation of such local parameters is not
yet available in the current version of the toolbox.
Outlook
First, we aim to improve optPBN to be capable of optimising
local parameters. In addition, we plan to introduce the concept of
penalisation for increasing model size (E`s and a) as implemented in
CellNOpt and CellNOptR as a part of our objective function in order
to generate better results. Second, we foresee that other global
optimisation techniques, e.g., Simulated Annealing, Pattern
Search methods, or Mode Hopping Metropolis sampling could
be integrated into the optPBN pipeline. Third, the ambiguity of
Boolean rules formulation to properly represent biochemical
reactions is yet to be addressed. Lastly, we envisage many useful
applications from implementing the optPBN toolbox to study
biological systems such as the inference of gene regulatory
networks from microarray data and the identification of crosstalk
signalling’s relevancy in mammalian signal transduction networks
based on experimental data in a context-specific manner.
Software Availability and Requirements
– Project name: optPBN
– Project home page: http://sourceforge.net/projects/
optpbn
– Operating system(s): Platform independent
– Programming language: Matlab (and C++ for grid-based
version)
– Other requirements: BN/PBN Toolbox, Systems Biology
Toolbox 2 (with Message Passing Interface (MPI) and
ParadisEO for grid-based version)
– License: GNU GPL v3.0 (with CeCILL license required for
ParadisEO framework)
– Restrictions: no restrictions except for commercial use
Supporting Information
Figure S1 Compared results from optPBN and CellNOpt
on the original toy model of Saez-Rodriguez et al. [A] The
model structure of the original toy model of Saez-Rodriguez et al.
[18] is shown on the left panel. The experimental descriptions and
the corresponding artificial measurement data are shown in the
left and right tables respectively. [B] The results from CellNOpt
under a defined set of size penalty (0#a,0.23 and E`s = 0.58)
identifies the AND (&) gate for the connection between PI3K and
TNFa to NFkB. The interaction from Raf was identified as the
only factor that activates ERK. [C] The results from the
optimisation with optPBN toolbox in discrete mode are in a good
agreement with CellNOpt for NFkB. Furthermore, optPBN also
discovered the OR (|) gate for the connection between Raf and
NFkB to ERK as an additional solution.
(ZIP)
File S1 Stand-alone version of optPBN toolbox. The
compressed zip file contains all scripts of optPBN toolbox in
stand-alone version. Also, it contains three scripts of optPBN
toolbox in grid-based version with the tag ‘_G5K.m’ for the
analysis of optimisation results obtained from the grid-based
pipeline which runs on a local computer. To install the stand-alone
version, a wrap-up script in Matlab (install.m) is provided for the
ease of installation. The installations of the BN/PBN toolbox [20]
and the optimisation toolbox of Systems Biology Toolbox 2
(SBtoolbox2) [24], which are required for the running of optPBN
toolbox, are also included in the wrap-up script. The grid-based
version of the optPBN toolbox is provided separately and can be
downloaded at https://sourceforge.net/projects/optpbn. It com-
prises all packages needed for running the algorithm on a cluster
or on a grid-based infrastructure. This includes the ParadisEO 1.1
framework (evolutionary algorithms and parallelisation support),
MPICH2, LibXML2, GSL, MCR and the optPBN grid-based
implementation in itself. A detailed description on the installation
and execution of the grid-based pipeline can be found in File S9.
(ZIP)
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File S2 Computational scripts of all examples and the
corresponding original result files. The compressed zip file
contains the optPBN optimisation pipeline in the form of Matlab
scripts (.m) for all examples used in this study (case study 1, case
study 2, toy models of Saez-Rodriguez et al., i.e. case study 3, and
Boolean model of apoptosis of Schlatter et al., i.e. case study 4).
For the results presented in this article, the integrated
optimisation problems of the first 3 case studies were optimised
by using the stand-alone version of the optPBN pipeline applying
particle swarm optimisation as the optimiser on a single local
machine. The last case study (Schlatter’s model, i.e. case study 4),
due to a complex optimisation problem, was optimised by using
the grid-based version of the optPBN pipeline applying a
combined differential evolution and evolutionary algorithms as
the optimisers on the Grid’5000. The corresponding results from
the optimisations of each model presented in the article are
included in a matrix format (.mat and .log) for further analysis on
the distributions of optimised parameters. A complete set of result
files for four case studies and the results from additional analysis
as presented in File S8 can be downloaded at https://
sourceforge.net/projects/optpbn.
(ZIP)
File S3 Manual of the optPBN toolbox. The PDF manual
provides a detailed description of the optPBN optimisation pipeline.
A step-by-step guideline on how to use the optPBN toolbox
together with the explanation of the core idea for each
computational script is provided in the document.
(PDF)
File S4 Grid-based pipeline of optPBN toolbox. The PDF
documentation provides a description on the grid-based pipeline of
the optPBN toolbox. It also describes a strategy to combine two
optimisation algorithms, evolutionary algorithm (EA) and differ-
ential evolution algorithm (DE), as a single optimiser. An
optimisation run on Grid’5000 is demonstrated as an example.
(PDF)
File S5 Derivations of the two-state Markov chain
approach’s formulas. The PDF documentation provides the
corrected derivations of the two-state Markov chain approach’s
formulas in relation to the derivations presented in the original
work of Raftery and Lewis [30]. The term l which refers to
1{a{b in the calculation of m0 should be replaced with lj j (i.e.,
1{a{bj j). In addition, W which denotes the standard normal
cumulative distribution function in the calculation of N should be
substituted with the inverse of its function, W21, after derivations.
(PDF)
File S6 Results of optPBN for four case studies. The
spread sheet provides a complete set of results generated from the
optPBN pipeline for the four case studies. Different numbers of
(selection probability) parameter samplings from optimisers and a
range of accuracy parameter ‘r’ from 0.01 to 0.05 are explored.
Computation time and quality of model fitting were reported for
both stand-alone and grid-based versions.
(XLSX)
File S7 Normalised and justified experimental data for
the study of apoptosis model from Schlatter et al. The
spread sheet provides a detailed description of the measurement
data that were used for the optimisation of the Boolean and
probabilistic Boolean models of apoptosis from Schlatter et al. The
pipeline on background subtraction and normalisation of exper-
imental data with the justification on the saturation of the signal
for p17 form of activated Caspase 3 is described in detail.
(XLS)
File S8 Analysis of the approximation of steady-state
distributions with different initial conditions and accu-
racies. The spread sheet presents the steady-state probability of
output nodes in case study 4 which are approximated by optPBN
applying a fixed set of selection probabilities (randomly generated)
with different sets of initial conditions. Three sets of initial
conditions (random, all zeros, and all ones) together with two levels
of accuracies (r = 0.025 and r = 0.01) were explored. Steady-state
probabilities of output nodes and parameters of two-state Markov
chain approach are shown. The differences of these values across
different sets of initial conditions and across two levels of
accuracies are also presented.
(XLS)
File S9 Installation guide for the grid-based pipeline of
optPBN and an execution example on Grid’5000. The PDF
documentation provides a list of commands to set-up the grid-
based version of the optPBN toolbox on a cluster or on a grid-based
infrastructure. An example set of commands to reserve resources
and to execute an optimisation task on Grid’5000 is also included.
(PDF)
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